LifeStance Health Group (NASDAQ:LFST) Posts Earnings Results, Beats Estimates By $0.02 EPS

LifeStance Health Group (NASDAQ:LFST) announced its quarterly earnings data on Thursday. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02, Zacks reports. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. LifeStance Health Group updated its Q1 2025 guidance to EPS and its FY 2025 guidance to EPS.

LifeStance Health Group Price Performance

Shares of LFST traded up $0.23 during mid-day trading on Thursday, hitting $7.74. The company’s stock had a trading volume of 4,482,653 shares, compared to its average volume of 1,191,754. The firm has a 50-day simple moving average of $7.78 and a 200 day simple moving average of $7.20. The firm has a market capitalization of $2.96 billion, a P/E ratio of -29.77 and a beta of 1.28. LifeStance Health Group has a 1-year low of $4.64 and a 1-year high of $9.20. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on LFST. Barclays increased their target price on LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, LifeStance Health Group has an average rating of “Hold” and an average target price of $8.70.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.